THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 152 filers reported holding THERAVANCE INC in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,353,000 | +19.8% | 223,141 | -18.4% | 0.01% | +16.7% |
| Q3 2015 | $1,964,000 | -86.6% | 273,462 | -66.2% | 0.01% | -83.3% |
| Q2 2015 | $14,607,000 | +47.6% | 808,353 | +28.4% | 0.04% | +56.5% |
| Q1 2015 | $9,896,000 | +42.8% | 629,487 | +28.5% | 0.02% | +35.3% |
| Q4 2014 | $6,930,000 | +27.9% | 489,785 | +54.4% | 0.02% | +30.8% |
| Q3 2014 | $5,420,000 | -17.1% | 317,143 | +44.4% | 0.01% | -23.5% |
| Q2 2014 | $6,539,000 | -11.3% | 219,591 | -7.9% | 0.02% | -19.0% |
| Q1 2014 | $7,376,000 | +15.9% | 238,392 | +33.5% | 0.02% | +10.5% |
| Q4 2013 | $6,365,000 | -14.5% | 178,533 | -2.0% | 0.02% | -29.6% |
| Q3 2013 | $7,447,000 | +305.6% | 182,114 | +282.2% | 0.03% | +237.5% |
| Q2 2013 | $1,836,000 | – | 47,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,144,301 | $718,144,000 | 20.35% |
| Litespeed Management, L.L.C. | 1,636,994 | $58,359,000 | 8.44% |
| Realm Partners LLC | 240,794 | $8,585,000 | 7.27% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,828,059 | $100,820,000 | 4.97% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,456,503 | $265,824,000 | 3.15% |
| SECTORAL ASSET MANAGEMENT INC | 1,973,188 | $70,344,000 | 3.03% |
| Foundation Asset Management, LP | 221,796 | $7,907,000 | 2.06% |
| Rhenman & Partners Asset Management AB | 132,000 | $4,706,000 | 1.84% |
| BB BIOTECH AG | 888,244 | $31,666,000 | 1.69% |
| HealthCor Management, L.P. | 725,000 | $25,846,000 | 1.57% |